Dermal Drug Delivery: From Innovation to Production, 1st Edition (Hardback) book cover

Dermal Drug Delivery

From Innovation to Production, 1st Edition

Edited by Tapash K. Ghosh

CRC Press

240 pages | 60 B/W Illus.

Purchasing Options:$ = USD
Hardback: 9781466582705
pub: 2020-01-16
SAVE ~$29.99
Available for pre-order. Item will ship after 16th January 2020
$149.95
$119.96
x


FREE Standard Shipping!

Description

With the continued advancement of better-quality control and patient outcome reporting systems, changes in the development, control, and regulation of all pharmaceutical delivery systems including transdermal and topical products have been happening on a continuous basis. In light of various quality issues that have been reported by patients and practitioners resulting in the recall or removal of products from the market, both the pharmaceutical industries and regulatory agencies have been adopting new measures to address these issues. With chapters written by experts in this field, this book takes a 21st century multidisciplinary and cross-functional look at these dosage forms to improve the development, design, manufacturing, quality, clinical performance, safety, and regulation of these products.

This book offers a wealth of up-to-date information organized in a logical sequence corresponding to various stages of research, development, and commercialization of dermal drug delivery products. The authors have been carefully selected from different sectors of pharmaceutical science for their expertise in their selected areas to present objectively a balanced view of the current state of these products development and commercialization via regulatory approval. Their insights will provide useful information to others to ensure the successful development of the next generation dermal drug products.

Key Features:

  • Presents current advancements including new technologies of transdermal and topical dosage forms.

  • Presents challenges in the development of the new generation of transdermal and topical dosage forms.
  • Introduces new technologies and QbD (quality by design) aspects of manufacturing and control strategies.
  • Includes new perspectives on pre-clinical and clinical development, regulatory considerations, safety and quality.
  • Discusses regulatory challenges, gaps, and future considerations for dermal drug delivery systems.

Table of Contents

Chapter 1 Dermal and Transdermal Drug Delivery Systems: An Overview and Recent Advancements

Kenneth A Walters & Majella E Lane

Chapter 2 Preclinical and Clinical Safety and Assessment of Transdermal and Topical Dermatological Products

Lindsey C. Yeh & Howard I. Maibach

Chapter 3 Selection considerations for membranes and models for in-vitro/ex-vivo permeation studies

Pei-Chin Tsai, Tannaz Ramezanli, Dina Wadie, Sonia Trehan, Nathaly Martos, Zheng Zhang, Bozena Michniak-Kohn

Chapter 4 Design, Development, Manufacturing and Testing of Transdermal Drug Delivery Systems

Timothy A. Peterson, Steven M. Wick & Chan Ko

Chapter 5 Quality by Design (QbD) principles in the development of Transdermal Drug Delivery Products

Muralikrishnan Angamuthu, H.N. Shivakumar & S. Narasimha Murthy

Chapter 6 Microneedles for Drug Delivery: Industrial and Regulatory Perspectives

Lisa A. Dick, Dan M. Dohmeier, Ann M. Purrington & Scott A. Burton

Chapter 7 Biopharmaceutics Aspects of Dermally Applied Drug Delivery Systems

Tapash Ghosh

Chapter 8 Quality and Performance Tests for Dermal Drug Delivery Systems

Margareth R.C. Marques, Tony Bennett & Gregory Fieldson

Chapter 9 Perspective on Clinical Trials for Dermal Drug Delivery Systems

John T. Farrar & Shamir Kalaria

Chapter 10 Regulatory Standards for Approval of Topical Dermatological Drug Products

April C. Braddy & Dale P. Conner

Chapter 11 Gaps and Future Considerations for Development of Dermal Transdermal and Topical Delivery Systems

Caroline Stransinger

Chapter 12 Regulatory Challenges in Chemistry, Manufacturing and Controls: Gaps and Future Consideration for Locally Acting Topical Dermal Systems

Shulin Ding

Chapter 13 Development of Topical and Transdermal Dosage Forms: Regulatory Perspective

Amit Mitra & Sarah A. Ibrahim

Chapter 14 Innovations and Future Prospects of Dermal Delivery Systems

Rashmi Upasani, Anushree Herwadkar, Neha Singh and Ajay K. Banga

About the Editor

Tapash K. Ghosh is employed by the Office of Clinical Pharmacology and Biopharmaceutics at CDER, FDA. Before joining the FDA, he held faculty positions in the division of pharmaceutical sciences at the Massachusetts College of Pharmacy in Boston and Howard University in Washington, DC. He is the author of numerous scientific publications and the principle editor of other scientific books.

Subject Categories

BISAC Subject Codes/Headings:
MED017000
MEDICAL / Dermatology
MED071000
MEDICAL / Pharmacology
MED072000
MEDICAL / Pharmacy
SCI013000
SCIENCE / Chemistry / General